Kennedy Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-33,327
Closed -$566K 741
2016
Q3
$566K Buy
+33,327
New +$617K 0.01% 675

Other funds holding IRMD

Kennedy Capital Management's IRMD Position: Q4 2016 in Review

Kennedy Capital Management sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 33,327 shares — an estimated $566K sold.

Kennedy Capital Management first reported a position in IRMD in Q3 2016 and held it in 1 quarter. The position peaked at $566K in Q3 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • Kennedy Capital Management reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
  • Kennedy Capital Management sold 33,327 iRadimed shares in Q4 2016, an estimated $566K.
  • Kennedy Capital Management first reported a position in iRadimed in Q3 2016 and held it in 1 quarter.
  • Kennedy Capital Management's iRadimed position peaked at $566K in Q3 2016.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on Kennedy Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.